ScanSource (SCSC) Financials

$40.53 -0.49 (-1.19%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$40.54 +0.01 (+0.02%)

As of 07/18/2025 07:20 PM Eastern

Annual Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2014	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Net Income / (Loss) Attributable to Common Shareholders	82	65	64	69	33	58	-193	11	89	90	77
Consolidated Net Income / (Loss)	82	65	64	69	33	58	-193	11	89	90	77
Net Income / (Loss) Continuing Operations	82	65	64	69	35	65	-79	45	89	88	77
Total Pre-Tax Income	123	100	96	101	63	84	-72	58	119	122	100
Total Operating Income	122	101	97	88	69	95	-65	61	122	136	90
Total Gross Profit	301	327	355	384	369	393	356	351	427	449	399
Total Revenue	2,914	3,219	3,540	3,568	3,165	3,250	3,048	3,151	3,530	3,788	3,260
Operating Revenue	2,914	3,219	3,540	3,568	3,165	3,250	3,048	3,151	3,530	3,788	3,260
Total Cost of Revenue	2,613	2,892	3,185	3,185	2,795	2,857	2,692	2,800	3,103	3,338	2,861
Operating Cost of Revenue	2,613	2,892	3,185	3,185	2,795	2,857	2,692	2,800	3,103	3,338	2,861
Total Operating Expenses	179	226	259	295	300	298	421	289	304	313	309
Selling, General & Admin Expense	192	211	240	265	232	244	260	247	275	286	277
Depreciation Expense	-	5.36	7.33	9.40	12	12	13	13	11	11	11
Amortization Expense	-	6.60	9.80	16	19	18	20	19	18	17	16
Restructuring Charge	-	-	-	-	-	8.65	0.60	9.26	0.00	0.00	4.36
Total Other Income / (Expense), net	1.32	-1.54	-0.87	13	-5.96	-11	-6.81	-3.95	-3.54	-14	9.52
Interest Expense	0.73	1.80	2.12	3.22	9.12	13	12	6.93	6.52	20	13
Interest & Investment Income	2.36	2.64	3.45	5.33	3.71	1.82	5.83	3.10	4.33	7.41	9.38
Other Income / (Expense), net	-0.31	-2.38	-2.19	11	-0.55	0.25	-0.41	-0.12	-1.35	-1.66	13
Income Tax Expense	41	34	32	32	28	19	7.45	12	30	34	23
Net Income / (Loss) Discontinued Operations	-	-	-	-	-2.30	-7.26	-113	-35	0.10	1.72	0.00
Basic Earnings per Share	$2.89	$2.29	$2.40	$2.74	$1.30	$2.25	($7.59)	$0.42	$3.48	$3.57	$3.10
Weighted Average Basic Shares Outstanding	28.34M	28.56M	26.47M	25.32M	25.52M	25.64M	25.38M	25.42M	25.50M	25.14M	24.87M
Diluted Earnings per Share	$2.86	$2.27	$2.38	$2.71	$1.29	$2.24	($7.59)	$0.42	$3.45	$3.54	$3.06
Weighted Average Diluted Shares Outstanding	28.60M	28.80M	26.69M	25.52M	25.62M	25.73M	25.38M	25.52M	25.76M	25.36M	25.22M
Weighted Average Basic & Diluted Shares Outstanding	28.30M	28.60M	26.50M	25.30M	25.50M	25.24M	25.36M	25.50M	25.19M	24.84M	24.03M

This table shows ScanSource's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	24	26	21	19	15	33	13	16	17	17	17
Consolidated Net Income / (Loss)	24	26	21	19	15	33	13	16	17	17	17
Net Income / (Loss) Continuing Operations	24	26	21	17	15	33	13	16	17	17	17
Total Pre-Tax Income	32	36	30	23	19	40	18	23	23	20	24
Total Operating Income	35	39	34	27	24	27	18	22	18	18	22
Total Gross Profit	113	115	112	109	107	101	94	97	102	102	100
Total Revenue	944	1,011	886	947	876	885	753	746	776	747	705
Operating Revenue	944	1,011	886	947	876	885	753	746	776	747	705
Total Cost of Revenue	830	896	774	838	770	784	658	649	674	646	605
Operating Cost of Revenue	830	896	774	838	770	784	658	649	674	646	605
Total Operating Expenses	79	76	77	81	82	74	77	75	84	83	78
Selling, General & Admin Expense	72	69	71	74	75	67	67	68	72	74	70
Depreciation Expense	2.76	2.68	2.64	2.83	2.80	2.96	2.69	2.77	2.86	2.90	2.32
Amortization Expense	4.24	4.15	4.17	4.19	4.19	4.04	3.75	3.74	4.36	5.00	4.94
Restructuring Charge	-	-	0.00	-	0.00	0.00	3.92	-	5.07	0.31	0.00
Other Special Charges / (Income)	-	-	-	-	-	0.00	0.00	-	-	1.14	0.90
Total Other Income / (Expense), net	-2.61	-3.24	-4.37	-3.83	-4.94	13	0.41	0.82	5.33	1.27	1.89
Interest Expense	3.45	5.06	5.72	5.56	5.59	3.36	2.00	2.09	2.11	1.97	1.84
Interest & Investment Income	1.59	2.03	1.71	2.09	1.33	2.12	2.65	3.29	2.66	2.69	2.84
Other Income / (Expense), net	-0.75	-0.21	-0.36	-0.35	-0.68	14	-0.24	-0.38	4.78	0.54	0.88
Income Tax Expense	8.24	10	8.69	6.37	3.72	7.32	5.15	6.60	5.99	2.66	6.80
Basic Earnings per Share	$0.95	$1.02	$0.84	$0.76	$0.62	$1.31	$0.51	$0.66	$0.70	$0.72	$0.75
Weighted Average Basic Shares Outstanding	25.20M	25.29M	25.20M	25.14M	24.89M	25.04M	25.03M	24.87M	24.15M	23.81M	23.28M
Diluted Earnings per Share	$0.94	$1.01	$0.83	$0.76	$0.61	$1.29	$0.50	$0.66	$0.69	$0.70	$0.74
Weighted Average Diluted Shares Outstanding	25.45M	25.50M	25.44M	25.36M	25.18M	25.33M	25.44M	25.22M	24.65M	24.22M	23.60M
Weighted Average Basic & Diluted Shares Outstanding	25.25M	25.35M	24.90M	24.84M	24.97M	25.17M	24.71M	24.03M	0.00	23.46M	22.60M

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2014	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Net Change in Cash & Equivalents	47	-73	-60	-4.87	-35	-1.71	11	28	-25	-1.81	149
Net Cash From Operating Activities	48	76	52	95	25	16	182	117	-124	-36	372
Net Cash From Continuing Operating Activities	48	76	52	95	31	16	182	117	-124	-36	372
Net Income / (Loss) Continuing Operations	82	65	64	69	35	65	-79	45	89	88	77
Consolidated Net Income / (Loss)	82	65	64	69	33	58	-193	11	89	90	77
Net Income / (Loss) Discontinued Operations	-	-	-	-	-2.30	-7.26	-113	-35	0.10	1.72	0.00
Depreciation Expense	7.38	12	17	25	34	34	35	34	30	29	28
Amortization Expense	0.31	0.30	0.30	0.29	0.33	0.35	0.42	0.42	0.42	0.58	0.39
Non-Cash Adjustments To Reconcile Net Income	11	7.26	15	15	9.44	-2.43	125	5.96	13	14	3.80
Changes in Operating Assets and Liabilities, net	-53	-9.45	-43	-15	-48	-80	101	31	-257	-167	262
Net Cash From Discontinued Operating Activities	-	-	-	-	-6.64	-	-	-	0.00	0.00	0.00
Net Cash From Investing Activities	-11	-81	-74	-96	-152	-38	-55	32	-3.72	-8.26	9.05
Net Cash From Continuing Investing Activities	-11	-81	-74	-96	-151	-38	-55	32	-3.72	-8.26	9.05
Purchase of Property, Plant & Equipment	-11	-21	-12	-8.85	-7.00	-5.80	-6.39	-2.36	-6.85	-9.98	-8.56
Divestitures	-	-	-	-	-	0.00	0.00	34	3.13	1.72	18
Net Cash From Discontinued Investing Activities	-	-	-	-	-1.16	-	-	-	0.00	0.00	0.00
Net Cash From Financing Activities	9.29	-57	-36	-3.51	101	31	-153	-119	108	40	-228
Net Cash From Continuing Financing Activities	9.29	-57	-36	-3.51	101	31	-153	-119	108	40	-228
Repayment of Debt	-4.28	-133	-1,308	-1,794	-2,150	-2,134	-2,196	-1,957	-2,040	-2,442	-1,447
Repurchase of Common Equity	0.00	-19	-100	-21	0.00	-9.48	-6.08	0.00	-18	-16	-43
Issuance of Debt	0.00	94	1,377	1,813	2,301	2,211	2,086	1,882	2,166	2,499	1,260
Other Financing Activities, net	14	1.02	-4.51	-1.94	-50	-36	-36	-43	-0.45	-1.55	1.94
Net Cash From Discontinued Financing Activities	-	-	-	-	-0.35	-	-	-	0.00	0.00	0.00
Effect of Exchange Rate Changes	0.91	-11	-2.60	-	-	0.56	-3.64	3.71	-4.76	2.69	-3.64
Cash Interest Paid	0.74	1.08	1.71	2.83	8.61	13	12	6.41	6.07	19	13
Cash Income Taxes Paid	24	36	34	31	36	31	17	12	29	29	27

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	2.49	26	-29	-1.20	6.47	2.34	114	26	-40	-35	36
Net Cash From Operating Activities	-48	-27	55	-15	94	63	160	55	45	-6.19	66
Net Cash From Continuing Operating Activities	-48	-27	55	-15	94	63	160	55	45	-6.19	66
Net Income / (Loss) Continuing Operations	24	26	21	17	15	33	13	16	17	17	17
Consolidated Net Income / (Loss)	24	26	21	19	15	33	13	16	17	17	17
Depreciation Expense	7.23	7.06	7.07	7.26	7.22	7.26	6.74	6.79	7.47	8.13	7.49
Amortization Expense	0.29	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10
Non-Cash Adjustments To Reconcile Net Income	2.44	3.29	4.78	3.53	6.94	-12	3.80	4.67	4.17	7.29	4.69
Changes in Operating Assets and Liabilities, net	-82	-63	22	-43	64	35	137	27	16	-39	36
Net Cash From Investing Activities	-0.68	-3.58	-2.29	-1.71	-2.32	15	-2.42	-1.65	-59	0.77	-1.42
Net Cash From Continuing Investing Activities	-0.68	-3.58	-2.29	-1.71	-2.32	15	-2.42	-1.65	-59	0.77	-1.42
Purchase of Property, Plant & Equipment	-0.68	-3.58	-2.29	-3.43	-2.32	-2.55	-2.42	-1.27	-2.38	-1.97	-1.42
Net Cash From Financing Activities	53	55	-82	14	-83	-78	-43	-24	-27	-26	-31
Net Cash From Continuing Financing Activities	53	55	-82	14	-83	-78	-43	-24	-27	-26	-31
Repayment of Debt	-525	-597	-712	-608	-671	-626	-131	-19	-9.06	-22	-14
Repurchase of Common Equity	-	-	-11	-4.93	0.00	-1.25	-20	-22	-28	-24	-29
Issuance of Debt	579	653	640	627	589	546	108	17	8.38	18	12
Other Financing Activities, net	-0.59	-1.11	0.12	0.03	-1.51	3.16	0.18	0.11	2.18	2.51	0.00
Effect of Exchange Rate Changes	-1.34	1.38	0.84	1.81	-1.26	1.50	-1.03	-2.86	0.61	-3.38	2.19

This table presents ScanSource's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2014	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Total Assets	1,335	1,477	1,491	1,718	1,945	2,067	1,692	1,672	1,937	2,068	1,779
Total Current Assets	1,216	1,244	1,229	1,281	1,362	1,477	1,203	1,220	1,524	1,657	1,405
Cash & Equivalents	195	122	61	56	26	19	29	63	38	36	185
Accounts Receivable	464	523	560	637	646	523	443	569	729	753	582
Inventories, net	505	553	559	531	596	554	455	470	615	758	513
Prepaid Expenses	34	47	49	56	95	84	95	118	142	110	125
Plant, Property, & Equipment, net	32	47	52	57	73	0.00	0.00	0.00	0.00	0.00	34
Total Noncurrent Assets	88	186	210	381	510	590	489	452	414	411	341
Goodwill	32	67	93	201	298	311	214	219	214	217	206
Intangible Assets	16	46	51	102	137	121	122	105	84	68	38
Noncurrent Deferred & Refundable Income Taxes	-	39	29	29	22	15	25	22	16	18	20
Other Noncurrent Operating Assets	39	34	37	49	53	113	128	106	99	108	77
Total Liabilities & Shareholders' Equity	1,335	1,477	1,491	1,718	1,945	2,067	1,692	1,672	1,937	2,068	1,779
Total Liabilities	532	668	717	881	1,079	1,153	1,014	940	1,131	1,163	855
Total Current Liabilities	500	599	585	656	710	701	719	733	814	787	669
Short-Term Debt	5.85	12	12	31	44	42	54	7.84	12	6.92	7.86
Accounts Payable	422	501	471	513	563	488	454	635	714	691	588
Current Deferred & Payable Income Tax Liabilities	8.69	4.18	3.06	7.73	13	3.96	5.89	2.50	0.03	9.88	7.90
Other Current Liabilities	64	81	99	105	91	65	77	88	88	79	66
Total Noncurrent Liabilities	33	69	132	225	369	452	295	208	317	376	185
Long-Term Debt	5.43	5.97	77	97	249	323	211	135	260	323	136
Other Noncurrent Operating Liabilities	27	59	52	126	118	97	80	68	54	49	49
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	803	809	774	837	866	914	678	731	807	905	924
Total Preferred & Common Equity	803	809	774	837	866	914	678	731	807	905	924
Preferred Stock	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	803	809	774	837	866	914	678	731	807	905	924
Common Stock	168	157	67	61	68	64	64	71	64	58	26
Retained Earnings	651	716	780	849	882	940	747	758	847	937	1,014
Accumulated Other Comprehensive Income / (Loss)	-17	-65	-73	-73	-84	-90	-133	-98	-105	-90	-116

This table presents ScanSource's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	9/30/2023	12/31/2023	3/31/2024	9/30/2024	12/31/2024	3/31/2025
Total Assets	2,000	2,131	1,980	1,899	1,781	1,783	1,787	1,703	1,725
Total Current Assets	1,588	1,719	1,578	1,507	1,405	1,416	1,352	1,284	1,310
Cash & Equivalents	40	66	37	43	45	159	145	111	146
Accounts Receivable	745	780	684	692	663	590	567	549	563
Inventories, net	676	762	753	656	575	529	504	492	476
Prepaid Expenses	126	111	103	117	122	138	136	132	125
Plant, Property, & Equipment, net	0.00	0.00	36	0.00	0.00	36	33	30	30
Total Noncurrent Assets	413	411	366	391	376	331	401	389	385
Goodwill	212	214	215	215	208	208	233	228	229
Intangible Assets	79	76	72	64	45	42	78	73	68
Noncurrent Deferred & Refundable Income Taxes	13	15	14	16	19	19	17	18	18
Other Noncurrent Operating Assets	109	106	65	96	103	63	73	70	70
Total Liabilities & Shareholders' Equity	2,000	2,131	1,980	1,899	1,781	1,783	1,787	1,703	1,725
Total Liabilities	1,173	1,268	1,101	983	827	839	866	802	823
Total Current Liabilities	794	837	744	701	611	643	666	610	632
Short-Term Debt	4.10	5.04	5.98	8.21	7.86	7.86	12	9.90	9.60
Accounts Payable	711	749	657	618	541	556	579	520	541
Current Deferred & Payable Income Tax Liabilities	5.27	6.05	4.44	8.11	3.65	4.79	6.38	8.33	13
Other Current Liabilities	74	77	77	67	58	75	69	71	68
Total Noncurrent Liabilities	379	431	357	282	217	196	200	192	192
Long-Term Debt	322	378	305	240	161	138	134	132	130
Other Noncurrent Operating Liabilities	54	51	49	39	56	58	66	60	61
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	827	862	879	915	954	944	921	901	902
Total Preferred & Common Equity	827	862	879	915	954	944	921	901	902
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	827	862	879	915	954	944	921	901	902
Common Stock	66	68	60	60	64	46	2.98	0.00	0.00
Retained Earnings	871	897	918	952	985	998	1,031	1,032	1,023
Accumulated Other Comprehensive Income / (Loss)	-110	-103	-99	-96	-95	-100	-113	-131	-122

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2014	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.27%	10.47%	9.99%	0.79%	-11.31%	2.69%	-6.22%	3.38%	12.03%	7.30%	-13.94%
EBITDA Growth	113.97%	-13.78%	0.70%	11.15%	-17.14%	24.89%	-122.97%	421.57%	58.58%	8.14%	-19.29%
EBIT Growth	135.58%	-18.45%	-4.42%	4.96%	-31.11%	38.74%	-168.83%	193.86%	96.87%	11.10%	-22.90%
NOPAT Growth	142.50%	-17.91%	-3.36%	-6.22%	-35.54%	89.31%	-161.90%	206.66%	88.33%	7.54%	-29.04%
Net Income Growth	135.96%	-20.01%	-2.75%	8.84%	-52.12%	73.73%	-434.49%	105.60%	722.58%	1.14%	-14.20%
EPS Growth	130.65%	-20.63%	4.85%	13.87%	-52.40%	73.64%	-438.84%	105.53%	721.43%	2.61%	-13.56%
Operating Cash Flow Growth	-63.13%	58.25%	-30.87%	81.72%	-73.85%	-35.37%	1,035.44%	-35.85%	-206.50%	71.24%	1,139.02%
Free Cash Flow Firm Growth	-82.80%	-206.74%	-58.51%	-48.69%	-292.19%	174.51%	17.60%	-40.01%	-240.26%	55.33%	731.87%
Invested Capital Growth	11.15%	13.97%	13.60%	13.41%	24.67%	-5.71%	-19.46%	-5.69%	28.10%	15.32%	-26.37%
Revenue Q/Q Growth	1.58%	3.16%	0.59%	1.13%	-16.05%	0.78%	10.87%	7.37%	3.20%	-0.40%	-5.81%
EBITDA Q/Q Growth	88.04%	-10.73%	-5.16%	4.66%	-0.64%	3.06%	-127.79%	332.09%	2.03%	-0.16%	-4.28%
EBIT Q/Q Growth	97.70%	-13.42%	-6.64%	4.05%	-1.01%	4.42%	-188.87%	181.14%	2.89%	0.15%	-4.99%
NOPAT Q/Q Growth	100.74%	-13.46%	-4.95%	8.26%	-11.92%	12.45%	-180.86%	192.09%	-0.06%	-1.05%	-6.15%
Net Income Q/Q Growth	97.71%	-14.01%	-5.25%	9.56%	-20.56%	2.11%	-632.38%	104.69%	-4.07%	-1.25%	-3.40%
EPS Q/Q Growth	98.61%	-14.02%	-2.86%	9.27%	-20.37%	2.28%	-634.51%	104.63%	-4.43%	-0.56%	-3.16%
Operating Cash Flow Q/Q Growth	-44.58%	79.01%	-28.18%	-15.31%	448.56%	147.06%	22.45%	-9.74%	-893.38%	63.94%	23.21%
Free Cash Flow Firm Q/Q Growth	-71.99%	64.11%	-119.98%	-76.21%	19.25%	393.62%	55.20%	-71.04%	-942.69%	43.81%	30.38%
Invested Capital Q/Q Growth	4.11%	-2.99%	-0.96%	1.94%	-2.76%	-16.37%	-29.99%	-3.39%	10.07%	4.03%	-5.16%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	10.33%	10.16%	10.04%	10.75%	11.67%	12.09%	11.67%	11.13%	12.08%	11.86%	12.24%
EBITDA Margin	4.43%	3.46%	3.17%	3.49%	3.26%	3.97%	-0.97%	3.02%	4.28%	4.31%	4.05%
Operating Margin	4.18%	3.15%	2.74%	2.47%	2.18%	2.92%	-2.13%	1.95%	3.46%	3.59%	2.77%
EBIT Margin	4.17%	3.08%	2.67%	2.79%	2.16%	2.92%	-2.15%	1.95%	3.42%	3.54%	3.17%
Profit (Net Income) Margin	2.81%	2.03%	1.80%	1.94%	1.05%	1.77%	-6.32%	0.34%	2.52%	2.37%	2.36%
Tax Burden Percent	66.44%	65.48%	66.26%	68.23%	52.58%	68.87%	268.41%	18.76%	74.86%	73.70%	77.18%
Interest Burden Percent	101.34%	100.85%	101.40%	102.13%	92.10%	88.06%	109.79%	93.76%	98.19%	90.78%	96.47%
Effective Tax Rate	33.56%	34.52%	33.74%	31.77%	43.76%	22.45%	0.00%	21.11%	25.23%	27.70%	22.82%
Return on Invested Capital (ROIC)	13.76%	10.03%	8.52%	7.04%	3.80%	6.67%	-4.71%	5.80%	9.87%	8.78%	6.70%
ROIC Less NNEP Spread (ROIC-NNEP)	13.22%	10.73%	10.02%	25.32%	0.46%	-0.86%	-92.11%	-22.89%	8.24%	5.58%	12.52%
Return on Net Nonoperating Assets (RNNOA)	-2.84%	-1.91%	-0.48%	1.55%	0.09%	-0.20%	-19.48%	-4.27%	1.68%	1.72%	1.73%
Return on Equity (ROE)	10.92%	8.12%	8.04%	8.59%	3.89%	6.47%	-24.20%	1.53%	11.55%	10.49%	8.42%
Cash Return on Invested Capital (CROIC)	3.20%	-3.03%	-4.22%	-5.53%	-18.16%	12.55%	16.84%	11.66%	-14.77%	-5.46%	37.07%
Operating Return on Assets (OROA)	9.72%	7.05%	6.38%	6.19%	3.74%	4.73%	-3.48%	3.65%	6.69%	6.70%	5.38%
Return on Assets (ROA)	6.54%	4.65%	4.29%	4.32%	1.81%	2.87%	-10.25%	0.64%	4.92%	4.48%	4.01%
Return on Common Equity (ROCE)	10.92%	8.12%	8.04%	8.59%	3.89%	6.47%	-24.20%	1.53%	11.55%	10.49%	8.42%
Return on Equity Simple (ROE_SIMPLE)	10.19%	8.09%	8.21%	8.27%	3.83%	6.30%	-28.40%	1.48%	11.01%	9.92%	8.34%
Net Operating Profit after Tax (NOPAT)	81	66	64	60	39	73	-45	49	91	98	70
NOPAT Margin	2.78%	2.06%	1.81%	1.69%	1.23%	2.26%	-1.49%	1.54%	2.59%	2.59%	2.14%
Net Nonoperating Expense Percent (NNEP)	0.54%	-0.70%	-1.50%	-18.28%	3.34%	7.53%	87.40%	28.69%	1.63%	3.20%	-5.82%
Cost of Revenue to Revenue	89.67%	89.84%	89.96%	89.25%	88.33%	87.91%	88.33%	88.87%	87.92%	88.14%	87.76%
SG&A Expenses to Revenue	6.61%	6.56%	6.78%	7.43%	7.34%	7.52%	8.52%	7.85%	7.80%	7.54%	8.51%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	6.15%	7.01%	7.30%	8.28%	9.49%	9.17%	13.80%	9.18%	8.62%	8.27%	9.47%
Earnings before Interest and Taxes (EBIT)	121	99	95	99	68	95	-65	61	121	134	103
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	129	111	112	125	103	129	-30	95	151	163	132
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.35	1.35	1.23	1.22	1.19	0.92	0.90	0.98	0.97	0.81	1.18
Price to Tangible Book Value (P/TBV)	1.44	1.56	1.51	1.91	2.39	1.74	1.78	1.76	1.55	1.19	1.61
Price to Revenue (P/Rev)	0.37	0.34	0.27	0.29	0.33	0.26	0.20	0.23	0.22	0.19	0.34
Price to Earnings (P/E)	13.28	16.65	14.97	14.73	31.08	14.53	0.00	66.36	8.85	8.20	14.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	7.53%	6.01%	6.68%	6.79%	3.22%	6.88%	0.00%	1.51%	11.30%	12.20%	7.04%
Enterprise Value to Invested Capital (EV/IC)	1.46	1.40	1.22	1.20	1.14	1.11	0.98	0.98	0.98	0.86	1.19
Enterprise Value to Revenue (EV/Rev)	0.31	0.31	0.28	0.31	0.41	0.36	0.28	0.25	0.29	0.27	0.32
Enterprise Value to EBITDA (EV/EBITDA)	6.99	8.85	8.73	8.76	12.56	9.18	0.00	8.36	6.74	6.30	7.99
Enterprise Value to EBIT (EV/EBIT)	7.43	9.95	10.34	10.99	18.95	12.46	0.00	12.98	8.43	7.67	10.18
Enterprise Value to NOPAT (EV/NOPAT)	11.15	14.84	15.26	18.14	33.43	16.11	0.00	16.43	11.15	10.48	15.11
Enterprise Value to Operating Cash Flow (EV/OCF)	18.91	13.05	18.76	11.51	52.30	73.82	4.65	6.82	0.00	0.00	2.83
Enterprise Value to Free Cash Flow (EV/FCFF)	48.02	0.00	0.00	0.00	0.00	8.57	5.21	8.18	0.00	0.00	2.73
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.02	0.11	0.15	0.34	0.40	0.39	0.20	0.34	0.36	0.16
Long-Term Debt to Equity	0.01	0.01	0.10	0.12	0.29	0.35	0.31	0.19	0.32	0.36	0.15
Financial Leverage	-0.22	-0.18	-0.05	0.06	0.20	0.24	0.21	0.19	0.20	0.31	0.14
Leverage Ratio	1.67	1.74	1.87	1.99	2.15	2.25	2.36	2.39	2.35	2.34	2.10
Compound Leverage Factor	1.69	1.76	1.90	2.03	1.98	1.98	2.59	2.24	2.30	2.12	2.03
Debt to Total Capital	1.39%	2.20%	10.25%	13.26%	25.23%	28.58%	28.10%	16.37%	25.16%	26.71%	13.48%
Short-Term Debt to Total Capital	0.72%	1.48%	1.34%	3.18%	3.76%	3.32%	5.74%	0.90%	1.08%	0.56%	0.74%
Long-Term Debt to Total Capital	0.67%	0.72%	8.91%	10.08%	21.48%	25.27%	22.36%	15.48%	24.09%	26.15%	12.74%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	98.61%	97.80%	89.75%	86.74%	74.77%	71.42%	71.90%	83.63%	74.84%	73.29%	86.52%
Debt to EBITDA	0.09	0.16	0.79	1.03	2.83	2.84	-8.94	1.50	1.79	2.02	1.09
Net Debt to EBITDA	-1.42	-0.93	0.24	0.58	2.58	2.69	-7.95	0.84	1.54	1.80	-0.31
Long-Term Debt to EBITDA	0.04	0.05	0.69	0.78	2.41	2.51	-7.12	1.42	1.72	1.98	1.03
Debt to NOPAT	0.14	0.27	1.38	2.13	7.54	4.98	-5.83	2.95	2.97	3.36	2.07
Net Debt to NOPAT	-2.27	-1.56	0.42	1.19	6.88	4.72	-5.18	1.66	2.55	2.99	-0.59
Long-Term Debt to NOPAT	0.07	0.09	1.20	1.62	6.41	4.40	-4.64	2.79	2.84	3.29	1.95
Altman Z-Score	5.03	4.58	4.63	4.09	3.35	3.25	3.00	3.45	3.50	3.56	4.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.43	2.08	2.10	1.95	1.92	2.11	1.67	1.66	1.87	2.11	2.10
Quick Ratio	1.32	1.08	1.06	1.06	0.95	0.77	0.66	0.86	0.94	1.00	1.15
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	19	-20	-32	-47	-185	138	162	97	-137	-61	386
Operating Cash Flow to CapEx	425.03%	363.75%	432.17%	1,072.17%	354.47%	276.56%	2,850.05%	4,941.47%	-1,815.65%	-358.44%	4,344.21%
Free Cash Flow to Firm to Interest Expense	25.71	-11.16	-14.97	-14.71	-20.33	10.50	13.29	14.07	-20.96	-3.09	29.61
Operating Cash Flow to Interest Expense	65.28	42.03	24.58	29.51	2.72	1.22	14.89	16.85	-19.06	-1.81	28.52
Operating Cash Flow Less CapEx to Interest Expense	49.92	30.47	18.89	26.76	1.95	0.78	14.37	16.51	-20.11	-2.31	27.86
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.33	2.29	2.39	2.22	1.73	1.62	1.62	1.87	1.96	1.89	1.69
Accounts Receivable Turnover	6.48	6.52	6.54	5.96	4.93	5.56	6.31	6.23	5.44	5.11	4.88
Inventory Turnover	5.76	5.47	5.73	5.84	4.96	4.97	5.34	6.05	5.72	4.87	4.50
Fixed Asset Turnover	112.01	82.11	71.55	65.50	48.84	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	6.66	6.27	6.55	6.47	5.20	5.44	5.71	5.14	4.60	4.75	4.47
Days Sales Outstanding (DSO)	56.34	55.96	55.78	61.21	74.01	65.68	57.88	58.63	67.13	71.44	74.73
Days Inventory Outstanding (DIO)	63.36	66.76	63.70	62.46	73.59	73.46	68.40	60.29	63.80	75.02	81.03
Days Payable Outstanding (DPO)	54.77	58.26	55.75	56.43	70.23	67.13	63.89	70.98	79.33	76.82	81.60
Cash Conversion Cycle (CCC)	64.93	64.47	63.74	67.25	77.37	72.01	62.38	47.93	51.60	69.64	74.16
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	619	706	802	909	1,133	1,069	861	812	1,040	1,199	883
Invested Capital Turnover	4.96	4.86	4.70	4.17	3.10	2.95	3.16	3.77	3.81	3.38	3.13
Increase / (Decrease) in Invested Capital	62	86	96	107	224	-65	-208	-49	228	159	-316
Enterprise Value (EV)	902	986	979	1,092	1,297	1,184	846	797	1,019	1,030	1,053
Market Capitalization	1,086	1,089	952	1,020	1,031	837	611	716	786	736	1,095
Book Value per Share	$28.14	$28.27	$30.18	$33.07	$33.88	$35.56	$26.76	$28.71	$31.96	$36.36	$37.41
Tangible Book Value per Share	$26.45	$24.33	$24.57	$21.12	$16.87	$18.76	$13.51	$16.00	$20.12	$24.90	$27.53
Total Capital	814	827	863	965	1,159	1,280	943	874	1,078	1,235	1,068
Total Debt	11	18	88	128	292	366	265	143	271	330	144
Total Long-Term Debt	5.43	5.97	77	97	249	323	211	135	260	323	136
Net Debt	-184	-103	27	72	267	347	236	80	233	294	-41
Capital Expenditures (CapEx)	11	21	12	8.85	7.00	5.80	6.39	2.36	6.85	9.98	8.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)	527	536	594	599	670	800	509	432	683	841	558
Debt-free Net Working Capital (DFNWC)	722	658	655	655	695	819	539	495	721	877	743
Net Working Capital (NWC)	716	645	644	625	652	776	484	487	710	870	735
Net Nonoperating Expense (NNE)	-0.88	1.01	0.57	-9.04	5.65	16	147	38	2.55	8.43	-7.35
Net Nonoperating Obligations (NNO)	-184	-103	27	72	267	154	182	80	233	294	-41
Total Depreciation and Amortization (D&A)	7.69	12	17	25	35	34	36	34	30	29	28
Debt-free, Cash-free Net Working Capital to Revenue	18.08%	16.65%	16.78%	16.80%	21.17%	24.60%	16.71%	13.71%	19.35%	22.20%	17.11%
Debt-free Net Working Capital to Revenue	24.77%	20.43%	18.51%	18.37%	21.97%	25.20%	17.67%	15.70%	20.43%	23.16%	22.80%
Net Working Capital to Revenue	24.57%	20.05%	18.19%	17.51%	20.60%	23.89%	15.90%	15.45%	20.10%	22.98%	22.56%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.89	$2.29	$2.40	$2.74	$1.30	$2.25	($7.59)	$0.42	$3.48	$3.57	$3.10
Adjusted Weighted Average Basic Shares Outstanding	28.34M	28.56M	26.47M	25.32M	25.52M	25.64M	25.38M	25.42M	25.50M	25.14M	24.87M
Adjusted Diluted Earnings per Share	$2.86	$2.27	$2.38	$2.71	$1.29	$2.24	($7.59)	$0.42	$3.45	$3.54	$3.06
Adjusted Weighted Average Diluted Shares Outstanding	28.60M	28.80M	26.69M	25.52M	25.62M	25.73M	25.38M	25.52M	25.76M	25.36M	25.22M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	28.54M	27.62M	25.63M	25.43M	25.59M	25.24M	25.36M	25.50M	25.19M	24.84M	24.03M
Normalized Net Operating Profit after Tax (NOPAT)	72	68	65	64	60	92	44	56	91	98	73
Normalized NOPAT Margin	2.48%	2.12%	1.84%	1.79%	1.88%	2.83%	1.45%	1.78%	2.59%	2.59%	2.24%
Pre Tax Income Margin	4.23%	3.10%	2.71%	2.84%	1.99%	2.57%	-2.36%	1.83%	3.36%	3.22%	3.06%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	166.18	55.13	44.58	30.91	7.51	7.22	-5.35	8.86	18.52	6.78	7.94
NOPAT to Interest Expense	110.69	36.96	30.22	18.73	4.25	5.58	-3.72	7.00	14.00	4.97	5.35
EBIT Less CapEx to Interest Expense	150.82	43.57	38.89	28.16	6.74	6.78	-5.87	8.52	17.47	6.28	7.29
NOPAT Less CapEx to Interest Expense	95.33	25.41	24.54	15.97	3.49	5.14	-4.24	6.66	12.95	4.46	4.69
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	28.69%	157.51%	30.16%	0.00%	16.46%	-3.15%	0.00%	20.50%	17.43%	55.66%

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.06%	17.03%	4.67%	-1.57%	-7.15%	-12.50%	-15.01%	-21.23%	-11.49%	-15.52%	-6.34%
EBITDA Growth	10.15%	21.13%	1.55%	-0.74%	-26.26%	4.88%	-41.25%	-17.21%	-2.41%	-44.05%	27.63%
EBIT Growth	13.56%	26.72%	2.62%	0.74%	-31.44%	5.25%	-48.99%	-20.20%	-4.25%	-54.01%	34.22%
NOPAT Growth	14.23%	16.92%	2.28%	-4.73%	-25.29%	-21.81%	-48.54%	-21.98%	-32.86%	-27.21%	28.45%
Net Income Growth	8.92%	10.67%	-9.80%	-5.69%	-35.81%	27.17%	-39.65%	-14.44%	9.99%	-47.89%	36.12%
EPS Growth	9.30%	12.22%	-8.79%	-2.56%	-35.11%	27.72%	-39.76%	-13.16%	13.11%	-45.74%	48.00%
Operating Cash Flow Growth	14.92%	-45.97%	84.60%	80.60%	293.01%	335.15%	192.04%	458.69%	-52.07%	-109.79%	-58.75%
Free Cash Flow Firm Growth	-173.12%	-56.28%	-127.46%	32.71%	105.86%	156.24%	227.53%	337.89%	1,720.44%	30.56%	-77.91%
Invested Capital Growth	25.34%	26.57%	22.02%	15.32%	0.70%	-8.61%	-19.23%	-26.37%	-17.78%	-13.48%	-3.83%
Revenue Q/Q Growth	-1.92%	7.14%	-12.43%	6.96%	-7.48%	0.97%	-14.94%	-0.86%	3.95%	-3.62%	-5.71%
EBITDA Q/Q Growth	20.60%	11.33%	-11.41%	-16.55%	-10.41%	58.34%	-50.37%	17.59%	5.61%	-9.22%	13.20%
EBIT Q/Q Growth	27.68%	14.89%	-13.53%	-20.58%	-13.10%	76.38%	-58.09%	24.25%	4.26%	-15.28%	22.30%
NOPAT Q/Q Growth	24.50%	7.91%	-13.27%	-18.24%	-2.37%	12.94%	-42.92%	23.96%	-15.98%	22.45%	0.72%
Net Income Q/Q Growth	20.53%	7.04%	-17.54%	-11.35%	-17.97%	112.07%	-60.87%	25.69%	5.45%	0.47%	2.22%
EPS Q/Q Growth	20.51%	7.45%	-17.82%	-8.43%	-19.74%	111.48%	-61.24%	32.00%	4.55%	1.45%	5.71%
Operating Cash Flow Q/Q Growth	38.41%	44.52%	303.96%	-127.83%	712.89%	-32.40%	153.31%	-65.82%	-18.10%	-113.80%	1,167.58%
Free Cash Flow Firm Q/Q Growth	3.94%	-10.25%	16.31%	24.08%	108.37%	958.05%	89.78%	41.62%	-35.98%	-24.12%	-67.89%
Invested Capital Q/Q Growth	7.05%	5.91%	-2.22%	4.03%	-6.53%	-3.88%	-13.59%	-5.16%	4.37%	1.16%	-3.95%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	12.02%	11.41%	12.62%	11.47%	12.15%	11.39%	12.55%	13.04%	13.10%	13.61%	14.22%
EBITDA Margin	4.41%	4.59%	4.64%	3.62%	3.51%	5.50%	3.21%	3.80%	3.87%	3.64%	4.37%
Operating Margin	3.70%	3.90%	3.87%	2.88%	2.75%	3.03%	2.33%	2.93%	2.27%	2.47%	3.17%
EBIT Margin	3.62%	3.88%	3.83%	2.84%	2.67%	4.67%	2.30%	2.88%	2.89%	2.54%	3.29%
Profit (Net Income) Margin	2.55%	2.54%	2.40%	1.99%	1.76%	3.70%	1.70%	2.16%	2.19%	2.28%	2.47%
Tax Burden Percent	74.47%	71.10%	70.94%	80.18%	80.60%	81.72%	71.33%	70.92%	73.92%	86.52%	71.95%
Interest Burden Percent	94.56%	92.27%	88.19%	87.10%	81.80%	97.00%	103.76%	105.58%	102.45%	103.81%	104.33%
Effective Tax Rate	25.53%	28.90%	29.06%	27.14%	19.40%	18.28%	28.67%	29.08%	26.08%	13.48%	28.05%
Return on Invested Capital (ROIC)	9.95%	9.89%	9.96%	7.10%	7.38%	7.89%	5.52%	6.51%	5.20%	6.42%	7.43%
ROIC Less NNEP Spread (ROIC-NNEP)	9.04%	8.93%	8.45%	6.70%	5.76%	12.80%	5.75%	6.97%	9.03%	7.83%	-6.36%
Return on Net Nonoperating Assets (RNNOA)	2.46%	2.62%	2.06%	2.06%	1.62%	3.10%	0.82%	0.96%	1.01%	0.66%	0.07%
Return on Equity (ROE)	12.41%	12.51%	12.02%	9.16%	9.00%	11.00%	6.35%	7.47%	6.21%	7.08%	7.50%
Cash Return on Invested Capital (CROIC)	-13.04%	-14.10%	-10.36%	-5.46%	7.49%	16.66%	28.41%	37.07%	25.75%	20.12%	10.54%
Operating Return on Assets (OROA)	7.08%	7.48%	7.62%	5.38%	5.10%	8.57%	4.23%	4.88%	4.95%	4.41%	5.59%
Return on Assets (ROA)	4.98%	4.91%	4.77%	3.76%	3.36%	6.80%	3.13%	3.66%	3.75%	3.96%	4.19%
Return on Common Equity (ROCE)	12.41%	12.51%	12.02%	9.16%	9.00%	11.00%	6.35%	7.47%	6.21%	7.08%	7.50%
Return on Equity Simple (ROE_SIMPLE)	10.98%	10.81%	10.35%	0.00%	8.87%	9.25%	8.45%	0.00%	8.54%	6.99%	7.49%
Net Operating Profit after Tax (NOPAT)	26	28	24	20	19	22	13	16	13	16	16
NOPAT Margin	2.75%	2.77%	2.75%	2.10%	2.22%	2.48%	1.66%	2.08%	1.68%	2.13%	2.28%
Net Nonoperating Expense Percent (NNEP)	0.91%	0.96%	1.50%	0.41%	1.62%	-4.91%	-0.22%	-0.46%	-3.83%	-1.41%	13.79%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	1.95%	-	-	-	1.53%	1.54%
Cost of Revenue to Revenue	87.98%	88.59%	87.38%	88.53%	87.85%	88.61%	87.45%	86.96%	86.90%	86.39%	85.78%
SG&A Expenses to Revenue	7.59%	6.83%	7.98%	7.85%	8.61%	7.56%	8.85%	9.18%	9.25%	9.89%	9.89%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.33%	7.51%	8.75%	8.59%	9.41%	8.35%	10.22%	10.11%	10.83%	11.14%	11.05%
Earnings before Interest and Taxes (EBIT)	34	39	34	27	23	41	17	21	22	19	23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	42	46	41	34	31	49	24	28	30	27	31
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.80	0.86	0.88	0.81	0.82	1.04	1.17	1.18	1.25	0.00	0.88
Price to Tangible Book Value (P/TBV)	1.24	1.29	1.30	1.19	1.18	1.41	1.60	1.61	1.89	0.00	1.32
Price to Revenue (P/Rev)	0.18	0.20	0.20	0.19	0.20	0.28	0.32	0.34	0.37	0.00	0.27
Price to Earnings (P/E)	7.33	7.91	8.48	8.20	9.27	11.21	13.90	14.21	14.68	0.00	11.81
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	13.65%	12.64%	11.79%	12.20%	10.78%	8.92%	7.20%	7.04%	6.81%	0.00%	8.47%
Enterprise Value to Invested Capital (EV/IC)	0.85	0.89	0.91	0.86	0.86	1.03	1.18	1.19	1.25	0.00	0.88
Enterprise Value to Revenue (EV/Rev)	0.26	0.28	0.27	0.27	0.26	0.31	0.32	0.32	0.37	0.00	0.27
Enterprise Value to EBITDA (EV/EBITDA)	6.14	6.46	6.39	6.30	6.29	7.19	7.95	7.99	8.80	0.00	6.80
Enterprise Value to EBIT (EV/EBIT)	7.62	7.92	7.80	7.67	7.76	8.86	10.06	10.18	11.27	0.00	9.19
Enterprise Value to NOPAT (EV/NOPAT)	10.06	10.68	10.53	10.48	10.48	12.88	14.75	15.11	18.16	0.00	13.07
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	9.02	5.67	3.63	2.83	3.58	0.00	4.96
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	11.45	5.92	3.70	2.73	4.39	0.00	8.23
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.39	0.44	0.35	0.36	0.27	0.18	0.15	0.16	0.16	0.16	0.16
Long-Term Debt to Equity	0.39	0.44	0.35	0.36	0.26	0.17	0.15	0.15	0.15	0.15	0.14
Financial Leverage	0.27	0.29	0.24	0.31	0.28	0.24	0.14	0.14	0.11	0.08	-0.01
Leverage Ratio	2.35	2.39	2.27	2.34	2.24	2.15	2.06	2.10	2.01	1.88	1.90
Compound Leverage Factor	2.22	2.21	2.00	2.04	1.83	2.09	2.14	2.22	2.06	1.95	1.98
Debt to Total Capital	28.30%	30.74%	26.14%	26.71%	21.33%	15.03%	13.38%	13.48%	13.65%	13.61%	13.42%
Short-Term Debt to Total Capital	0.36%	0.40%	0.50%	0.56%	0.71%	0.70%	0.72%	0.74%	1.09%	0.95%	0.92%
Long-Term Debt to Total Capital	27.95%	30.34%	25.64%	26.15%	20.62%	14.33%	12.66%	12.74%	12.56%	12.66%	12.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	71.70%	69.26%	73.86%	73.29%	78.67%	84.97%	86.62%	86.52%	86.35%	86.39%	86.58%
Debt to EBITDA	2.11	2.35	1.90	2.02	1.63	1.09	1.06	1.09	1.11	1.29	1.20
Net Debt to EBITDA	1.85	1.94	1.67	1.80	1.35	0.80	-0.10	-0.31	0.00	0.29	-0.06
Long-Term Debt to EBITDA	2.08	2.32	1.86	1.98	1.57	1.04	1.00	1.03	1.02	1.20	1.12
Debt to NOPAT	3.45	3.88	3.13	3.36	2.71	1.95	1.96	2.07	2.29	2.49	2.31
Net Debt to NOPAT	3.02	3.21	2.76	2.99	2.25	1.43	-0.18	-0.59	0.01	0.55	-0.11
Long-Term Debt to NOPAT	3.41	3.83	3.07	3.29	2.62	1.86	1.86	1.95	2.11	2.32	2.15
Altman Z-Score	3.29	3.26	3.55	3.39	3.67	4.12	4.07	3.93	3.88	0.00	3.65
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.00	2.05	2.12	2.11	2.15	2.30	2.20	2.10	2.03	2.11	2.07
Quick Ratio	0.99	1.01	0.97	1.00	1.05	1.16	1.16	1.15	1.07	1.08	1.12
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-199	-219	-184	-139	12	123	234	332	212	161	52
Operating Cash Flow to CapEx	-7,084.65%	-751.45%	2,397.81%	-444.93%	4,040.30%	2,479.37%	6,617.81%	4,310.16%	1,887.58%	-313.63%	4,648.98%
Free Cash Flow to Firm to Interest Expense	-57.72	-43.37	-32.13	-25.06	2.09	36.74	117.04	159.00	100.68	81.79	28.18
Operating Cash Flow to Interest Expense	-14.05	-5.31	9.60	-2.74	16.75	18.82	80.04	26.24	21.26	-3.14	35.98
Operating Cash Flow Less CapEx to Interest Expense	-14.25	-6.02	9.20	-3.36	16.33	18.06	78.83	25.63	20.13	-4.14	35.21
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.96	1.93	1.99	1.89	1.91	1.84	1.84	1.69	1.71	1.74	1.70
Accounts Receivable Turnover	5.42	5.40	5.73	5.11	5.18	4.98	5.43	4.88	5.02	4.99	5.16
Inventory Turnover	5.44	5.01	4.99	4.87	4.92	4.74	4.76	4.50	4.77	4.92	5.12
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	96.03	0.00	0.00	0.00	90.68
Accounts Payable Turnover	4.84	4.73	4.92	4.75	4.93	4.91	5.03	4.47	4.62	4.95	4.69
Days Sales Outstanding (DSO)	67.35	67.54	63.68	71.44	70.48	73.25	67.20	74.73	72.72	73.19	70.73
Days Inventory Outstanding (DIO)	67.16	72.86	73.19	75.02	74.16	77.07	76.69	81.03	76.58	74.14	71.30
Days Payable Outstanding (DPO)	75.42	77.12	74.22	76.82	73.97	74.32	72.54	81.60	78.96	73.72	77.77
Cash Conversion Cycle (CCC)	59.09	63.28	62.65	69.64	70.67	76.00	71.36	74.16	70.34	73.61	64.27
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,113	1,179	1,153	1,199	1,121	1,077	931	883	921	932	895
Invested Capital Turnover	3.61	3.57	3.63	3.38	3.33	3.19	3.32	3.13	3.09	3.01	3.26
Increase / (Decrease) in Invested Capital	225	247	208	159	7.75	-101	-222	-316	-199	-145	-36
Enterprise Value (EV)	951	1,054	1,045	1,030	958	1,113	1,095	1,053	1,155	0.00	791
Market Capitalization	665	738	772	736	753	989	1,109	1,095	1,154	0.00	798
Book Value per Share	$32.83	$34.16	$34.67	$36.36	$36.84	$38.19	$37.51	$37.41	$38.32	$37.83	$38.43
Tangible Book Value per Share	$21.30	$22.66	$23.33	$24.90	$25.62	$28.04	$27.61	$27.53	$25.39	$25.21	$25.79
Total Capital	1,153	1,245	1,190	1,235	1,163	1,122	1,090	1,068	1,066	1,043	1,042
Total Debt	326	383	311	330	248	169	146	144	146	142	140
Total Long-Term Debt	322	378	305	323	240	161	138	136	134	132	130
Net Debt	286	316	274	294	205	124	-13	-41	0.52	31	-6.53
Capital Expenditures (CapEx)	0.68	3.58	2.29	3.43	2.32	2.55	2.42	1.27	2.38	1.97	1.42
Debt-free, Cash-free Net Working Capital (DFCFNWC)	757	821	802	841	772	757	622	558	553	574	542
Debt-free Net Working Capital (DFNWC)	798	887	839	877	815	802	781	743	698	684	688
Net Working Capital (NWC)	794	882	833	870	806	795	773	735	686	674	678
Net Nonoperating Expense (NNE)	1.94	2.30	3.10	1.07	3.98	-11	-0.29	-0.58	-3.94	-1.10	-1.36
Net Nonoperating Obligations (NNO)	286	316	274	294	205	124	-13	-41	0.52	31	-6.53
Total Depreciation and Amortization (D&A)	7.52	7.15	7.17	7.35	7.31	7.36	6.84	6.89	7.57	8.23	7.59
Debt-free, Cash-free Net Working Capital to Revenue	20.94%	21.81%	21.09%	22.20%	20.75%	21.08%	17.97%	17.11%	17.50%	18.98%	18.22%
Debt-free Net Working Capital to Revenue	22.06%	23.58%	22.07%	23.16%	21.90%	22.33%	22.57%	22.80%	22.10%	22.64%	23.13%
Net Working Capital to Revenue	21.95%	23.45%	21.91%	22.98%	21.68%	22.11%	22.34%	22.56%	21.73%	22.31%	22.81%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.95	$1.02	$0.84	$0.76	$0.62	$1.31	$0.51	$0.66	$0.70	$0.72	$0.75
Adjusted Weighted Average Basic Shares Outstanding	25.20M	25.29M	25.20M	25.14M	24.89M	25.04M	25.03M	24.87M	24.15M	23.81M	23.28M
Adjusted Diluted Earnings per Share	$0.94	$1.01	$0.83	$0.76	$0.61	$1.29	$0.50	$0.66	$0.69	$0.70	$0.74
Adjusted Weighted Average Diluted Shares Outstanding	25.45M	25.50M	25.44M	25.36M	25.18M	25.33M	25.44M	25.22M	24.65M	24.22M	23.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	25.25M	25.35M	24.90M	24.84M	24.97M	25.17M	24.71M	24.03M	0.00	23.46M	22.60M
Normalized Net Operating Profit after Tax (NOPAT)	26	28	24	20	19	22	15	16	17	17	17
Normalized NOPAT Margin	2.75%	2.77%	2.75%	2.10%	2.22%	2.48%	2.03%	2.08%	2.16%	2.30%	2.37%
Pre Tax Income Margin	3.42%	3.58%	3.38%	2.48%	2.19%	4.53%	2.39%	3.04%	2.96%	2.64%	3.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.90	7.75	5.93	4.84	4.19	12.29	8.65	10.31	10.63	9.64	12.65
NOPAT to Interest Expense	7.54	5.54	4.26	3.57	3.48	6.53	6.25	7.44	6.18	8.10	8.75
EBIT Less CapEx to Interest Expense	9.70	7.04	5.53	4.23	3.78	11.53	7.44	9.70	9.50	8.64	11.87
NOPAT Less CapEx to Interest Expense	7.34	4.83	3.86	2.96	3.06	5.77	5.04	6.83	5.05	7.10	7.98
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	19.32%	22.42%	17.43%	0.00%	19.17%	32.72%	55.66%	90.36%	149.35%	152.45%

Key Financial Trends

ScanSource delivered a mixed Q3 2025, with strong free cash flow and operating cash flow improvements, alongside continued revenue pressure year-over-year.

Net cash from operating activities surged to $66.1 million in Q3 2025, up from –$6.2 million in Q2 2025, reflecting improved working capital management.
Free cash flow to firm (FCFF) of $51.7 million in Q3 2025, after a large swing in Q2, underscores solid cash generation capability.
Net debt remained negative at –$6.5 million, translating to a net cash position and a net debt/EBITDA ratio of –0.056.
Sequential profitability improvements: EBITDA grew 13.2% Q/Q to $30.8 million and EBIT rose 22.3% Q/Q to $23.2 million in Q3 2025.
Return on invested capital (ROIC) climbed to 7.43% in Q3 2025 from 6.42% in Q2, indicating better capital efficiency.
Gross margin held steady at 14.2%, while SG&A expenses remained below 9.9% of revenue in Q3 2025.
Balance sheet strength: a current ratio of 2.07x and debt/equity of 0.155 indicate ample liquidity and conservative leverage.
Revenue declined 6.3% year-over-year in Q3 2025, though sequential decline moderated from Q2’s 15.5% drop.
Free cash flow growth plunged 77.9% Y/Y in Q3 2025, as higher working capital requirements offset operating gains.
Operating cash flow fell 58.8% year-over-year in Q3 2025 despite Q/Q improvement, highlighting volatile cash conversion.

07/19/25 01:29 AMAI Generated. May Contain Errors.

Frequently Asked Questions About ScanSource's Financials

When does ScanSource's financial year end?

According to the most recent income statement we have on file, ScanSource's fiscal year ends in June. Their fiscal year 2024 ended on June 30, 2024.

How has ScanSource's net income changed over the last 10 years?

ScanSource's net income appears to be on a downward trend, with a most recent value of $77.06 million in 2024, falling from $81.79 million in 2014. The previous period was $89.81 million in 2023. Find out what analysts predict for ScanSource in the coming months.

What is ScanSource's operating income?

ScanSource's total operating income in 2024 was $90.32 million, based on the following breakdown:

Total Gross Profit: $399.05 million
Total Operating Expenses: $308.73 million

How has ScanSource's revenue changed over the last 10 years?

Over the last 10 years, ScanSource's total revenue changed from $2.91 billion in 2014 to $3.26 billion in 2024, a change of 11.9%.

How much debt does ScanSource have?

ScanSource's total liabilities were at $854.78 million at the end of 2024, a 26.5% decrease from 2023, and a 60.5% increase since 2014.

How much cash does ScanSource have?

In the past 10 years, ScanSource's cash and equivalents has ranged from $19.31 million in 2019 to $194.85 million in 2014, and is currently $185.46 million as of their latest financial filing in 2024.

How has ScanSource's book value per share changed over the last 10 years?

Over the last 10 years, ScanSource's book value per share changed from 28.14 in 2014 to 37.41 in 2024, a change of 32.9%.

Related Companies

This page (NASDAQ:SCSC) was last updated on 7/19/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ScanSource (SCSC) Financials

Key Financial Trends

Frequently Asked Questions About ScanSource's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ScanSource (SCSC) Financials

Annual Income Statements for ScanSource

Quarterly Income Statements for ScanSource

Annual Cash Flow Statements for ScanSource

Quarterly Cash Flow Statements for ScanSource

Annual Balance Sheets for ScanSource

Quarterly Balance Sheets for ScanSource

Annual Metrics And Ratios for ScanSource

Quarterly Metrics And Ratios for ScanSource

Key Financial Trends

Frequently Asked Questions About ScanSource's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools